Tiverton Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Tiverton Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$928K	Buy	7,241 +525	+8%	+$70.4K	0.03%	314
2019 Q2	$958K	Buy	6,716 +4,085	+155%	+$549K	0.03%	277
2019 Q1	$376K	Buy	+2,631	New	+$343K	0.02%	425
2018 Q4	–	Sell	-1,148	Closed	-$193K	–	504
2018 Q3	$193K	Hold	1,148	–	–	0.01%	329
2018 Q2	$198K	Buy	+1,148	New	+$188K	0.01%	318

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Tiverton Asset Management's JAZZ Position: Q3 2019 in Review

Tiverton Asset Management increased its Jazz Pharmaceuticals (JAZZ) stake by 7.8% in Q3 2019, buying an estimated $70.4K and bringing the position to 7,241 shares worth $928K. The position accounts for 0.03% of the portfolio, ranked #314.

Tiverton Asset Management first reported a position in JAZZ in Q2 2018 and has held it in 5 quarters since. The position peaked at $958K in Q2 2019. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

Tiverton Asset Management held 7,241 shares of Jazz Pharmaceuticals worth $928K as of Q3 2019.
Tiverton Asset Management bought 525 Jazz Pharmaceuticals shares in Q3 2019, an estimated $70.4K.
Jazz Pharmaceuticals made up 0.03% of Tiverton Asset Management's portfolio in Q3 2019, its #314 holding.
Tiverton Asset Management first reported a position in Jazz Pharmaceuticals in Q2 2018 and has held it in 5 quarters since.
Tiverton Asset Management's Jazz Pharmaceuticals position peaked at $958K in Q2 2019.
406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.